These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 16823994)

  • 1. From Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines to current clinical practice : an overview of the pharmacological therapy of stable chronic obstructive pulmonary disorder.
    Incalzi RA; Corsonello A; Pedone C; Masotti G; Bellia V; Grassi V; Rengo F
    Drugs Aging; 2006; 23(5):411-20. PubMed ID: 16823994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort.
    Jochmann A; Scherr A; Jochmann DC; Miedinger D; Török SS; Chhajed PN; Tamm M; Leuppi JD
    Swiss Med Wkly; 2012; 142():w13567. PubMed ID: 22481636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD.
    Foda HD; Brehm A; Goldsteen K; Edelman NH
    Int J Chron Obstruct Pulmon Dis; 2017; 12():209-214. PubMed ID: 28123293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study.
    Hsieh MJ; Huang SY; Yang TM; Tao CW; Cheng SL; Lee CH; Kuo PH; Wu YK; Chen NH; Hsu WH; Hsu JY; Lin MS; Wang CC; Wei YF; Tsai YH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2949-2959. PubMed ID: 30310271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids.
    Proietti M; Agosti P; Lonati C; Corrao S; Perticone F; Mannucci PM; Nobili A; Harari S;
    J Am Med Dir Assoc; 2019 Oct; 20(10):1313-1317.e9. PubMed ID: 30852169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to GOLD guidelines in real-life COPD management in the Puglia region of Italy.
    Palmiotti GA; Lacedonia D; Liotino V; Schino P; Satriano F; Di Napoli PL; Sabato E; Mastrosimone V; Scoditti A; Carone M; Costantino E; Resta E; Attolini E; Foschino Barbaro MP
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2455-2462. PubMed ID: 30147311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data.
    Baker CL; Zou KH; Su J
    Int J Chron Obstruct Pulmon Dis; 2014; 9():431-9. PubMed ID: 24833898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
    Lee JK; Rhee CK; Kim K; Ra SW; Lee JH; Jung KS; Yoo KH; Kim YI; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2639-2647. PubMed ID: 31819397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey.
    Sen E; Guclu SZ; Kibar I; Ocal U; Yilmaz V; Celik O; Cimen F; Topcu F; Orhun M; Tereci H; Konya A; Ar I; Saryal S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2657-63. PubMed ID: 26715844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of chronic bronchitis and chronic pulmonary obstructive disease in primary care].
    Miravitlles M; Murio C; Guerrero T; Segú JL
    Arch Bronconeumol; 1999 Apr; 35(4):173-8. PubMed ID: 10330538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications.
    Ding B; Small M; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1527-1537. PubMed ID: 28579771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-life evaluation of COPD treatment in a Bulgarian population: a 1-year prospective, observational, noninterventional study.
    Ivanov Y; Nikolaev I; Nemeth I
    Int J Chron Obstruct Pulmon Dis; 2018; 13():653-663. PubMed ID: 29503539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonologists Adherence to the Chronic Obstructive Pulmonary Disease GOLD Guidelines: A Goal to Improve.
    Rajnoveanu RM; Rajnoveanu AG; Ardelean AB; Todea DA; Pop CM; Antoniu SA; Motoc NS; Chis AF; Fildan AP; Man MA
    Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32825456
    [No Abstract]   [Full Text] [Related]  

  • 14. Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis.
    Fitch K; Iwasaki K; Pyenson B; Plauschinat C; Zhang J
    Curr Med Res Opin; 2011 Jul; 27(7):1425-9. PubMed ID: 21599554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease.
    Franssen FM; Spruit MA; Wouters EF
    Int J Chron Obstruct Pulmon Dis; 2011; 6():493-501. PubMed ID: 22069360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPD awareness survey: do Belgian pulmonary physicians comply with the GOLD guidelines 2010?
    Decramer M; Brusselle G; Buffels J; Corhay JL; De Backer W; Degryse JM; Janssens W; Marchand E; Van den Brande P; Vincken W; Gayan-Ramirez G; Van Craenendonck V; Vandenberghe H; De Vuyst P;
    Acta Clin Belg; 2013; 68(5):325-40. PubMed ID: 24579239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
    Bathoorn E; Groenhof F; Hendrix R; van der Molen T; Sinha B; Kerstjens HA; Friedrich AW; Kocks JW
    Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COPD management according to old and new GOLD guidelines: an observational study with Italian general practitioners.
    Maio S; Baldacci S; Martini F; Cerrai S; Sarno G; Borbotti M; Pala AP; Murgia N; Viegi G;
    Curr Med Res Opin; 2014 Jun; 30(6):1033-42. PubMed ID: 24450467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.